KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Prepaid Assets (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 16 years of Prepaid Assets data on record, last reported at $16.7 million in Q2 2025.

  • For Q2 2025, Prepaid Assets rose 92.7% year-over-year to $16.7 million; the TTM value through Jun 2025 reached $16.7 million, up 92.7%, while the annual FY2024 figure was $10.2 million, 62.35% up from the prior year.
  • Prepaid Assets reached $16.7 million in Q2 2025 per RIGL's latest filing, up from $10.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $16.7 million in Q2 2025 and bottomed at $3.0 million in Q3 2023.
  • Average Prepaid Assets over 5 years is $7.9 million, with a median of $7.9 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: plummeted 51.03% in 2023, then soared 92.7% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $7.4 million in 2021, then increased by 11.43% to $8.3 million in 2022, then dropped by 24.19% to $6.3 million in 2023, then skyrocketed by 62.35% to $10.2 million in 2024, then soared by 64.13% to $16.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $16.7 million in Q2 2025, $10.2 million in Q4 2024, and $8.7 million in Q2 2024.